Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Harvard Business School
Federal Trade Commission

Generated: March 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206392

« Back to Dashboard

NDA 206392 describes ASPIRIN AND DIPYRIDAMOLE, which is a drug marketed by Amneal Pharms, Barr, Impax Labs Inc, Par Pharm Inc, Sandoz Inc, and Zydus Pharms Usa Inc, and is included in six NDAs. It is available from seven suppliers. Additional details are available on the ASPIRIN AND DIPYRIDAMOLE profile page.

The generic ingredient in ASPIRIN AND DIPYRIDAMOLE is aspirin; dipyridamole. There are twenty-one drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.
Summary for 206392
Applicant:Amneal Pharms
Ingredient:aspirin; dipyridamole
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 206392
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206392 ANDA AvKARE, Inc. 42291-116 N 42291-116-60
ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206392 ANDA American Health Packaging 60687-305 N 60687-305-32

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength25MG;200MG
Approval Date:Mar 8, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.